Cargando…

The side effects of immune checkpoint inhibitor therapy on the endocrine system

Immune checkpoint inhibitors (ICIs) are a relatively newer class of drugs approved for the treatment of malignancies such as melanoma, renal, bladder and lung cancer. Immune-related adverse events (IrAEs) involving the endocrine system are a common side effect of these drugs. The spectrum of endocri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goyal, Itivrita, Pandey, Manu Raj, Sharma, Rajeev, Chaudhuri, Ajay, Dandona, Paresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205006/ https://www.ncbi.nlm.nih.gov/pubmed/35435341 http://dx.doi.org/10.4103/ijmr.IJMR_313_19

Ejemplares similares

SAT-131 Asymptomatic Severe Hypoglycemia with Lactic Acidosis in a Case of Non-Hodgkin’s Lymphoma - an Unusual Phenomenon of Hyper-Warburgism
por: Goyal, Itivrita, et al.
Publicado: (2020)

Endocrine side effects of immune checkpoint inhibitors
por: Cardona, Zulma, et al.
Publicado: (2023)

Sodium‐glucose co‐transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician
por: Dandona, Paresh, et al.
Publicado: (2017)

Confirmed Hypoglycemia Without Whipple Triad: A Rare Case of Hyper-Warburgism
por: Goyal, Itivrita, et al.
Publicado: (2020)

SUN-560 Simvastatin Inhibits the Pro-Inflammatory and Pro-Atherogenic Effects of Cream in Obese Subjects
por: Goyal, Itivrita, et al.
Publicado: (2020)

Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
por: Profili, Nicia I., et al.
Publicado: (2023)

MON-359 Hollow Bones: A Case Report of Immobilization Osteoporosis in a Young Female
por: Bhat, Salman Zahoor, et al.
Publicado: (2020)

Mechanism of resistance to immune checkpoint inhibitors
por: Pandey, Manu R., et al.
Publicado: (2019)

Proinflammatory and Prothrombotic Effects of Hypoglycemia
por: Dandona, Paresh, et al.
Publicado: (2010)

THU513 Are Endocrinologists Using CTCAE Grading System For Endocrine Side Effects Of Cancer Treatment With Immune Checkpoint Inhibitors?
por: Arnouk, Nelly, et al.
Publicado: (2023)

Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
por: Natarajan, Sabareesh, et al.
Publicado: (2012)

Macronutrient intake, insulin secretion, oxidative stress & inflammation: Clinico-pathological implications
por: Dandona, Paresh, et al.
Publicado: (2016)

Hypothyroidism After Use of Immune Checkpoint Inhibitor Therapy in Patient With Graves' Disease: Cure?
por: Sharma, Rajeev
Publicado: (2022)

How we treat endocrine complications of immune checkpoint inhibitors
por: Paschou, S.A., et al.
Publicado: (2021)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
por: Karhapää, Hanna, et al.
Publicado: (2022)

SAT-491 Transient Thyrotoxicosis with Immune Checkpoint Inhibitors Therapy: The Importance of Endocrine Evaluation
por: Martins, Diana Cruz, et al.
Publicado: (2020)

PSAT342 Hypothyroidism After Use Of Immune Checkpoint Inhibitor Therapy In Patient With Graves’ Disease
por: Sharma, Rajeev
Publicado: (2022)

Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
por: Kwon, Hyemi, et al.
Publicado: (2022)

Testosterone Concentration in Young Patients With Diabetes
por: Chandel, Anil, et al.
Publicado: (2008)

Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
por: Makdissi, Antoine, et al.
Publicado: (2013)

Immune checkpoint inhibitor therapy for pediatric cancers: A mini review of endocrine adverse events
por: Ihara, Kenji
Publicado: (2019)

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
por: Duan, Lian, et al.
Publicado: (2020)

Immune-related endocrine disorders in novel immune checkpoint inhibition therapy
por: Min, Le
Publicado: (2016)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy
por: Higham, C E, et al.
Publicado: (2018)

CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy
por: McGinnis, Gwendolyn J, et al.
Publicado: (2017)

Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors
por: Heleno, Caio T, et al.
Publicado: (2021)

Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone
por: Ghanim, Husam, et al.
Publicado: (2019)

Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review
por: Stelmachowska-Banaś, Maria, et al.
Publicado: (2020)

Low Estradiol Concentrations in Men With Subnormal Testosterone Concentrations and Type 2 Diabetes
por: Dhindsa, Sandeep, et al.
Publicado: (2011)

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management
por: Girotra, Monica, et al.
Publicado: (2018)

Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists
por: Illouz, Frédéric, et al.
Publicado: (2017)

Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma
por: Kassi, Eva, et al.
Publicado: (2019)

Endocrine Toxicity and Outcomes in Patients With Metastatic Malignancies Treated With Immune Checkpoint Inhibitors
por: Al Ashi, Suleiman I, et al.
Publicado: (2021)

Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia
por: Calvo, Roser
Publicado: (2019)

Clinical Presentation of Immune-Related Endocrine Adverse Events during Immune Checkpoint Inhibitor Treatment
por: Chieng, Jenny Hui Ling, et al.
Publicado: (2022)

Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer
por: Manz, Salomon M., et al.
Publicado: (2021)

Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2023)

Immune checkpoint inhibitors in lymphoma: challenges and opportunities
por: Hatic, Haris, et al.
Publicado: (2021)

Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors
por: Iwama, Shintaro, et al.
Publicado: (2021)

Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
por: Farina, Antonio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dqii8dd8b5jiv0qhr4en8bi9dp